-
Recently, many pharmaceutical companies are frequently experiencing shareholder reductions
Time of Update: 2023-01-01
Like Teyi Pharmaceutical, on November 15, BrightPharma also issued an announcement that its major shareholder Zhong Weifang plans to reduce its shares in the company through block transactions within 3 months after 3 trading days from the date of disclosure of this announcement, and the total number of shares to reduce will not exceed 2% of the company's total share capital, that is, no more than 8.
-
Yasheng Pharmaceutical announced its 2022 interim results: the commercialization of Nerick ® has accelerated, and the key pipeline varieties have gradually entered the harvest period
Time of Update: 2022-10-03
Suzhou, China and Rockville, Maryland, USA, 27 August 2022 /PRNewswire/ -- AsiaPharma, a leading biopharmaceutical company dedicated to developing innovative drugs in therapeutic areas such as oncolog
-
Fosun Pharma was the first to reduce its holdings, but the pharmaceutical business grew against the trend, can it revitalize its glory in the future
Time of Update: 2022-09-20
This is fosun pharma's third largest equity acquisition transaction in the past 10 years, in 2020 and 2021, BioNTech stock price increased by 140% and 216% respectively due to the new crown epidemic, and as of the end of 2021, this investment has brought more than 2.
-
Industry: In March, it is recommended to pay attention to the oversold rebound in the pharmaceutical and biological sector
Time of Update: 2022-05-01
CITIC Construction Investment stated in the research report that after the previous adjustment and digestion, the pressure on the high valuation of the pharmaceutical sector has been gradually released, and the recent rebound is in line with expectations.
-
Baiji Shenzhou announced that shareholders offered to sell the public offering pricing
Time of Update: 2020-12-13
addition, the offering shareholder has granted the underwriter of the offering a total of 151,154 ADS over-alloned shares, less underwriting discounts and commissions, within 30 days at the public offering price.
-
26 even board, one-sign crazy earn 130,000! Wantai Bio's new share market value advances into TOP20
Time of Update: 2020-06-16
Pharmaceutical Network June 11th, June 9th, the high-profile new pharmaceutical shares Wantai Biological after 26 consecutive ups and downs, opened a word of up and down board, as of the day's close,
-
China Institute of electrical appliances successfully landed on the scientific innovation board of Shanghai Stock Exchange
Time of Update: 2019-11-12
On November 5, China Electric Appliance Research Institute Co., Ltd issued its shares to the public for the first time, and was listed on the Shanghai stock exchange scientific innovation board, becom
-
US pharmaceutical company mylan will pay $465 million and termination fee
Time of Update: 2016-10-11
Source: Wall Street news / SHIMENG 2016-10-11 according to the Wall Street Journal, American pharmaceutical company mylan agreed to pay $465 million to solve the U.S government's accusation that its e
